TDRKH anticorps (AA 36-355)

N° du produit ABIN6148980

Détail du produit anti-TDRKH anticorps

Antigène: TDRKH (Tudor and KH Domain Containing (TDRKH))

Épitope: AA 36-355

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TDRKH est non-conjugé

Application: Western Blotting (WB)

Séquence: RYRESREERL TFVGEDDIEI EMRVPQEAVK LIIGRQGANI KQLRKQTGAR IDVDTEDVGD ERVLLISGFP VQVCKAKAAI HQILTENTPV SEQLSVPQRS VGRIIGRGGE TIRSICKASG AKITCDKESE GTLLLSRLIK ISGTQKEVAA AKHLILEKVS EDEELRKRIA HSAETRVPRK QPISVRREDM TEPGGAGEPA LWKNTSSSME PTAPLVTPPP KGGGDMAVVV SKEGSWEKPS DDSFQKSEAQ AIPEMPMFEI PSPDFSFHAD EYLEVYVSAS EHPNHFWIQI VGSRSLQLDK LVNEMTQHYE NSVPEDLTVH

Réactivité croisée: Humain, Souris, Rat

Attributs du produit: Polyclonal Antibodies

Immunogène: Recombinant fusion protein containing a sequence corresponding to amino acids 36-355 of human TDRKH (NP_001077432.1).

Isotype: IgG

Information d'application

Indications d'application: WB,1:500 - 1:2000

Commentaires:

HIGH QUALITY

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur TDRKH

Antigène: TDRKH (Tudor and KH Domain Containing (TDRKH))

Autre désignation: TDRKH (TDRKH Produits)

Synonymes: anticorps RGD1311196, anticorps tdrd2, anticorps MGC85144, anticorps TDRD2, anticorps 2700091C21Rik, anticorps Tdrd2, anticorps tudor and KH domain containing, anticorps tudor and KH domain containing L homeolog, anticorps tudor and KH domain containing protein, anticorps Tdrkh, anticorps TDRKH, anticorps tdrkh.L, anticorps tdrkh

Sujet: Participates in the primary piRNA biogenesis pathway and is required during spermatogenesis to repress transposable elements and prevent their mobilization, which is essential for the germline integrity. The piRNA metabolic process mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Required for the final steps of primary piRNA biogenesis by participating in the processing of 31-37 nt intermediates into mature piRNAs. May act in pi-bodies and piP-bodies by transferring piRNA precursors or intermediates to or between these granules.,TDRKH,TDRD2,Epigenetics & Nuclear Signaling,Cell Biology & Developmental Biology,TDRKH

Poids moléculaire: 57 kDa/62 kDa

ID gène: 11022

UniProt: Q9Y2W6